Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLE Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Not applicableUnknownNCT06428539
What this trial is testing

T Regulatory Cells IN LUPUS NEPHRITIS

Who this might be right for
Lupus Nephritis
Assiut University 65
Testing effectiveness (Phase 2)UnknownNCT01539902
What this trial is testing

Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
CytoMed & Beike 25
Not applicableStudy completedNCT00881309
What this trial is testing

To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 94
Large-scale testing (Phase 3)Active Not RecruitingNCT05126277
What this trial is testing

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 452
Not applicableWithdrawnNCT04369495
What this trial is testing

BAFF Levels and Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Universidad de Antioquia
Large-scale testing (Phase 3)Looking for participantsNCT06904729
What this trial is testing

Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children

Who this might be right for
Lupus Nephritis
Guangzhou Women and Children's Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT00709722
What this trial is testing

Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nippon Kayaku Co., Ltd. 21
Post-approval studies (Phase 4)Looking for participantsNCT07719140
What this trial is testing

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

Who this might be right for
Childhood-onset Systemic Lupus ErythematosusLupus Nephritis (LN)
Peking Union Medical College Hospital 198
Large-scale testing (Phase 3)Ended earlyNCT01765842
What this trial is testing

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

Who this might be right for
Lupus Nephritis
Fundación Pública Andaluza Progreso y Salud 9
Large-scale testing (Phase 3)Ended earlyNCT02514967
What this trial is testing

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 3
Not applicableNot Yet RecruitingNCT07783711
What this trial is testing

Predictors of ICU Admission and In-Hospital Mortality in Hospitalized Patients With Lupus Nephritis: The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and C Reactive Protein to Serum Albumin Ratio

Who this might be right for
Lupus Nephritis (LN)
Khaled Samir Malak Nashed 55
Not applicableNot Yet RecruitingNCT07763821
What this trial is testing

Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.

Who this might be right for
System Lupus Erythematosus(SLE)
Assiut University 128
Not applicableUnknownNCT05358652
What this trial is testing

Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Fundacin Biomedica Galicia Sur 60
Not applicableUnknownNCT05082363
What this trial is testing

The Expression Profile of New Complement Components in Childhood Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 30
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Not applicableUnknownNCT02435368
What this trial is testing

The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear

Who this might be right for
Lupus Nephritis
The Third Affiliated Hospital of Southern Medical University 10
Not applicableUnknownNCT04534647
What this trial is testing

Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort

Who this might be right for
Lupus Nephritis
Liga Panamericana de Asociaciones de Reumatologia (PANLAR) 100
Not applicableLooking for participantsNCT07017868
What this trial is testing

Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients

Who this might be right for
Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
Sohag University 120
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Next Page